rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Philip & Daniele Barach Family Trust

10% owner

Company insider

Files Form 4 as: 10% owner, Celularity.

In numbers

Trades disclosed
14
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
19 Jun 2026
Last trade
23 Sep 2026
Last filed
25 Sep 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
CELU Celularity10% owner · Biotechnology · last 23 Sep 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
23 Sep 2026filed 25 Sep 2026CELU Celularityoption or derivative · BiotechnologySEC FORM 4 Code J—192,771filing
23 Sep 2026filed 25 Sep 2026CELU Celularityoption or derivative · BiotechnologySEC FORM 4 Code J—2,140,000filing
23 Sep 2026filed 25 Sep 2026CELU Celularityoption or derivative · BiotechnologySEC FORM 4 Code J—1,177,000filing
23 Sep 2026filed 25 Sep 2026CELU Celularityoption or derivative · BiotechnologySEC FORM 4 Code J—192,771filing
23 Sep 2026filed 25 Sep 2026CELU Celularityoption or derivative · BiotechnologySEC FORM 4 Code J—2,140,000filing
23 Sep 2026filed 25 Sep 2026CELU Celularityoption or derivative · BiotechnologySEC FORM 4 Code J—1,177,000filing
23 Sep 2026filed 25 Sep 2026CELU Celularityoption or derivative · BiotechnologySEC FORM 4 Code J—1,457,765filing
23 Sep 2026filed 25 Sep 2026CELU Celularityoption or derivative · BiotechnologySEC FORM 4 Code J—1,457,765filing
23 Sep 2026filed 25 Sep 2026CELU Celularityoption or derivative · BiotechnologySEC FORM 4 Code J—1,457,765filing
23 Sep 2026filed 25 Sep 2026CELU Celularityoption or derivative · BiotechnologySEC FORM 4 Code J—1,457,765filing
19 Jun 2026filed 23 Jun 2026CELU Celularityoption or derivative · BiotechnologySEC FORM 4 Code J—1,204,819filing
19 Jun 2026filed 23 Jun 2026CELU Celularityoption or derivative · BiotechnologySEC FORM 4 Code J—839,160filing
19 Jun 2026filed 23 Jun 2026CELU Celularityoption or derivative · BiotechnologySEC FORM 4 Code J—1,204,819filing
19 Jun 2026filed 23 Jun 2026CELU Celularityoption or derivative · BiotechnologySEC FORM 4 Code J—839,160filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Philip Alan BarachDirector and 10% owner · Director and 10% owner at Celularity, filing Form 4 there in the last year
Daniele Wolf Barach10% owner · 10% owner at Celularity, filing Form 4 there in the last year
John R. HainesSenior Exec Vice President · Senior Exec Vice President at Celularity, filing Form 4 there in the last year
Robert J. HaririDirector · Chief Executive Officer at Celularity, filing Form 4 there in the last year
Stephen BrigidoPres., Functional Regeneration · Pres., Functional Regeneration at Celularity, filing Form 4 there in the last year